Hanson supports ENTEX in the construction of Vaccine Manufacture and Innovation Centre
Published by Emily Thomas,
Deputy Editor
World Cement,
Hanson UK is supporting groundworks contractor, ENTEX, to help fast-track the construction of the UK’s first Vaccine Manufacture and Innovation Centre (VMIC).
The advanced facility, at Harwell Science Campus in Oxfordshire, is set to open its doors by 2021 – a year ahead of schedule due to the coronavirus pandemic.
Hanson is providing around 2 000 m3 of concrete for the groundworks package.
“We are working flat out to manage the accelerated requirements of the construction programme,” said Regional Director, James Moorhouse.
“It’s been testing, but we’ve managed to get supplies out at short-notice and will continue to play our part in delivering this nationally significant project so it can begin operations as quickly as possible.”
Following completion of the groundworks, the 75 000 square foot VMIC, designed by WHP Engineering, is expected to be ready for early fit-out in the summer.
Read the article online at: https://www.worldcement.com/europe-cis/12052020/hanson-supports-entex-in-the-construction-of-vaccine-manufacture-and-innovation-centre/
You might also like
The World Cement Podcast
In this special joint episode of the World Cement Podcast, and Cementing Europe’s future, the podcast of CEMBUREAU, David Bizley and Koen Coppenholle take a deep dive into the Clean Industrial Deal and a discussion of what it means for the European cement industry.
Listen for free today at www.worldcement.com/podcasts or subscribe and review on your favourite podcast app.
Amrize debuts as independent, publicly traded company
Amrize announces its debut today as an independent, publicly traded company with the completion of its 100% spin-off from Holcim.
